NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1500198 ·
Last close
$0.71
Market Cap
$6.43M
52W High
$6.12
52W Low
$0.71
ADV30
78,287
Next earnings
2026-12-15

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,973,105 1,182,609 -2,424,312 -2,006,331 6,186,095 2,047,596 2,418,552
Mar 2026 1,862,050 990,264 -2,397,197 -2,382,022 7,864,958 2,804,011 2,491,322
Dec 2025 2,892,635 1,567,828 -1,707,307 -1,437,890 8,577,602 3,561,616 2,175,677
Sep 2025 2,740,925 1,528,621 -1,371,064 -1,619,221 10,785,647 6,570,382 3,713,125

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,052,007
Investing CF
$-109,536
Financing CF
$1,169,456
CapEx
$-109,536
Dividends Paid
—
Buybacks
$-70,356
EPS Diluted TTM
$-0.88
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-84,436,030
Inventory
$2,290,254
Receivables
$1,098,965
ST Investments
—
EBIT TTM
$-7,445,464
Pretax Income TTM
$-7,445,464
Interest Exp TTM
$0
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,468,715
EBITDA
$-7,663,002
Free Cash Flow
$-4,566,159
Enterprise Value
$12,332,739
Total Cash
$2,047,596
Total Debt
$175,345
Shares Out
9,105,763
Trailing EPS
$-0.97
Book Value
$0.43
ROE
-124.7%
ROA
-58.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2025 9,097,692 -4,226,473 -3,605,374 10,785,647 3,713,125 7,072,522 -2,837,272
Sep 2024 3,453,003 -11,887,209 -12,318,110 5,369,940 4,547,927 822,013 -11,011,840
Sep 2023 1,952,441 -11,955,250 -11,859,491 8,097,314 1,847,910 6,249,404 -12,886,874
Sep 2022 171,169 -10,030,765 -9,999,613 12,822,609 3,218,245 9,604,364 -7,519,534

TTM Snapshot

Revenues TTM
$9,997,850
NetIncome TTM
$-7,149,111
OpCashFlow TTM
—
Assets (Latest)
$6,186,095
Forward EPS
$-0.28

Peers — same industry

TickerNameMarket CapLastDaily %
STME Stimcell Energetics Inc. $6.34M $0.30 —
CLGN CollPlant Biotechnologies Ltd $6.30M $3.33 —
NDRA ENDRA Life Sciences Inc. $5.88M $3.92 —
ARAY ACCURAY INC $7.33M $2.44 —
USAQ QHSLab, Inc. $5.52M $0.37 —

News headlines (Yahoo Finance, 1h cache)

INEO Appoints David Wambeke to Board of Directors
2026-11-03 12:00 · Yahoo
NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System
2026-10-29 12:00 · Yahoo
NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain
2026-10-27 12:00 · Yahoo
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
2026-10-22 12:31 · Yahoo
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
2026-10-08 20:01 · Yahoo
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
2026-10-05 13:17 · Yahoo
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
2026-08-27 13:05 · Yahoo
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript
2026-08-20 15:13 · Yahoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Call Highlights: Revenue Grows 16% ...
2026-08-17 19:03 · Yahoo
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
2026-08-03 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.